SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-016498
Filing Date
2019-05-07
Accepted
2019-05-07 16:09:55
Documents
63
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q kzr-10q_20190331.htm 10-Q 1875903
2 EX-10.1 kzr-ex101_57.htm EX-10.1 170030
3 EX-31.1 kzr-ex311_7.htm EX-31.1 19884
4 EX-31.2 kzr-ex312_8.htm EX-31.2 20028
5 EX-32.1 kzr-ex321_6.htm EX-32.1 9203
6 GRAPHIC gdd0vuvvzm13000001.jpg GRAPHIC 55675
  Complete submission text file 0001564590-19-016498.txt   6373714

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT kzr-20190331.xml EX-101.INS 1353041
8 XBRL TAXONOMY EXTENSION SCHEMA kzr-20190331.xsd EX-101.SCH 41600
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE kzr-20190331_cal.xml EX-101.CAL 46946
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE kzr-20190331_def.xml EX-101.DEF 92973
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE kzr-20190331_lab.xml EX-101.LAB 315859
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE kzr-20190331_pre.xml EX-101.PRE 245287
Mailing Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 4000 SHORELINE COURT, SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-822-5600
Kezar Life Sciences, Inc. (Filer) CIK: 0001645666 (see all company filings)

IRS No.: 473366145 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38542 | Film No.: 19803188
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences